1UB Stock Chart & Stats
€0.01
-€0.02(-53.57%)
At close: 4:00 PM EST
€0.01
-€0.02(-53.57%)
Day’s Range― - ―
52-Week Range€0.01 - €0.01
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€557.81K
Enterprise ValueN/A
Total Cash (Recent Filing)€16.57K
Total Debt (Recent Filing)€2.74M
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding89,588,610
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Cognetivity Neurosciences News
1UB FAQ
What was Cognetivity Neurosciences’s price range in the past 12 months?
Cognetivity Neurosciences lowest stock price was €0.01 and its highest was €0.01 in the past 12 months.
What is Cognetivity Neurosciences’s market cap?
Cognetivity Neurosciences’s market cap is €557.81K.
When is Cognetivity Neurosciences’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Cognetivity Neurosciences’s earnings last quarter?
Currently, no data Available
Is Cognetivity Neurosciences overvalued?
According to Wall Street analysts Cognetivity Neurosciences’s price is currently Overvalued.
Does Cognetivity Neurosciences pay dividends?
Cognetivity Neurosciences does not currently pay dividends.
What is Cognetivity Neurosciences’s EPS estimate?
Cognetivity Neurosciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cognetivity Neurosciences have?
Cognetivity Neurosciences has 89,588,610 shares outstanding.
What happened to Cognetivity Neurosciences’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Cognetivity Neurosciences?
Currently, no hedge funds are holding shares in DE:1UB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Cognetivity Neurosciences
Cognetivity Neurosciences Ltd. operates as a healthcare firm, specializing in the development of an integrated cognitive assessment platform. This advanced testing system, applicable across medical, commercial, and consumer environments, is designed to identify the earliest indicators of cognitive impairment by evaluating the performance of broad brain regions, thereby aiding in the diagnosis of dementia. The company also offers OptiMind, a dedicated wellness application. Established in 2015, Cognetivity Neurosciences Ltd. maintains its headquarters in Vancouver, Canada. The organization was previously known as Utor Capital Corp. before adopting its current name in December 2017.